ABCO : Summary for The Advisory Board Company - Yahoo Finance

U.S. Markets close in 6 hrs 8 mins

The Advisory Board Company (ABCO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.65-0.10 (-0.22%)
As of 9:51AM EDT. Market open.
People also watch
AAONACIWABAXAGIIAAWW
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close44.75
Open44.70
Bid44.45 x 200
Ask44.50 x 100
Day's Range44.50 - 44.90
52 Week Range24.85 - 51.23
Volume32,079
Avg. Volume773,733
Market Cap1.8B
Beta1.29
PE Ratio (TTM)20.02
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Advisory Board Co. breached its 50 day moving average in a Bearish Manner : ABCO-US : March 23, 2017
    Capital Cube2 hours ago

    The Advisory Board Co. breached its 50 day moving average in a Bearish Manner : ABCO-US : March 23, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for The Advisory Board Co.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day ... Read more (Read more...)

  • BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet
    Zacks3 days ago

    BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet

    BioDelivery Sciences International, Inc. (BDSI) reported loss of 29 cents per share in the fourth quarter of 2016, slightly wider than the Zacks Consensus Estimate of a loss of 28 cents.

  • Jazz Initiates Phase III Study for Narcolepsy Candidate
    Zacks7 days ago

    Jazz Initiates Phase III Study for Narcolepsy Candidate

    Jazz Pharmaceuticals plc (JAZZ) recently announced the initiation of patient enrollment in a phase III study evaluating the efficacy and safety of its pipeline candidate, JZP-258, for the potential treatment of adult narcolepsy patients.